 Norfloxacin spontaneous bacterial peritonitis recurrence cirrhosis results double-blind placebo-controlled trial Eighty cirrhotic patients episode spontaneous bacterial peritonitis multicenter double-blind trial long-term norfloxacin administration mg/day patients placebo patients prevention spontaneous bacterial peritonitis recurrence entry groups similar respect clinical laboratory data ascitic fluid protein polymorphonuclear concentrations number previous episodes spontaneous bacterial peritonitis causative organisms index spontaneous bacterial peritonitis Norfloxacin administration selective intestinal decontamination elimination aerobic gram-negative bacilli fecal flora significant changes microorganisms study patients effect norfloxacin fecal flora Fourteen patients placebo group norfloxacin group spontaneous bacterial peritonitis recurrence follow-up chi mean follow-up period mo range mo spontaneous bacterial peritonitis recurrences placebo group spontaneous bacterial peritonitis recurrences norfloxacin group aerobic gram-negative bacilli chi overall probability spontaneous bacterial peritonitis recurrence yr follow-up norfloxacin group placebo group probability spontaneous bacterial peritonitis recurrence aerobic gram-negative bacilli yr follow-up